European Union Drugs Agency (EUDA)

The European Union Drugs Agency (EUDA) is the leading authority on illicit drugs in Europe. Based in Lisbon, Portugal, the EUDA provides independent scientific evidence and analysis on all aspects of this constantly changing threat to individual lives and wider society. The EUDA contributes to EU and national policies to protect Europe's citizens from drug-related harms. It is an agency of the European Union.

Mission

Our new mission focuses on contributing to European Union (EU) preparedness on drugs through four main actions: anticipate, alert, respond, and learn.

Xchange Prevention Registry

Website
 - 
Xchange is an online registry dedicated to evidence-based prevention programmes, offering a wide array of thoroughly evaluated interventions. It serves as a valuable resource for implementers seeking effective strategies to address...

Launch event: European Drug Report 2023

Event Date
 - 
Brussels

How many new drugs were detected in Europe over the last year? What are the latest trends in drug production and trafficking? What substances are causing the most concern today? Find out more when the European Monitoring Centre for Drugs and Drug

Teens and substance use — what can parents do?

Video and audio recordings
Objective: To help adults manage risks relating to adolescent substance use in line with evidence-based prevention principles. Background: Smoking and drinking among 15–16-year-old school students are showing signs of decline, but there are...

EMCDDA Cocaine Hub

Website
Overview Cocaine is the hydrochloride salt produced from the leaves of the coca plant. Powder cocaine is typically snorted and less frequently injected. Crack is a smokable form of cocaine and is manufactured from cocaine hydrochloride...

Hexahydrocannabinol (HHC) and related substances

Book
Introduction The markets for hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSC) are rapidly evolving areas with relatively limited information currently available. The European situation presented in Section 1 can only...

Responding to stimulant use — developments in treatment

Video and audio recordings
Objective: To better understand current developments in the treatment of stimulant use. Background: Stimulant drugs are second only to cannabis as the most widely used class of illicit drug globally, accounting for 68 million past-year...

The future of drug monitoring in Europe until 2030

Book
 - 
Introduction Patterns of drug use and developments in the drug market in Europe are becoming more complex and dynamic, with major implications for drug monitoring and research. This observation prompted the European Monitoring Centre for...

European Drugs Summer School 2023

Event Date
 - 
Lisbon
Portugal

This two week in-person Summer School (26th of June to 7th of July 2023) prepares professionals and students to meet the complex policy challenges that face Europe and the World in the field of drugs.